Tuesday, 12 May 2020

Sleep Disorder Market Latest Comprehensive Research Report, SWOT Analysis And Covid-19 Impact Analysis

The sleep disorder market size is anticipated to reach over USD 2.61 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the sleep apnea devices dominated the global market, in terms of revenue. Asia-Pacific is expected to be the Fastest growing contributor to the global market revenue in 2017.

Sleep is complex neurological state that helps in restoring energy level in the body. Alterations in the quality and pattern if sleep may cause sleep disorder. Sleep disorder is defined as a sleep problem, which is characterized by snoring, insomnia, depression, and sleep apnea. Recently, in a study it is found that the approximately more than 75% of Americans from the age of 25 to 59 suffer from sleep disorder in the U.S. Sleep disorder is basically characterize by the difficulty in falling asleep, daytime fatigue, lack of concentration, anxiety, and depression.


The sleep disorder market is primarily driven by the increasing number individual population suffering from various mental disorders, and rising awareness for the treatment of sleep disorders in the coming years. Furthermore, the changing life style of the people, and rising preference to the sedentary life style to also support the market growth in the coming years. Additionally, changing working culture, increasing geriatric population, and lack of quality sleep to also boost the market growth during the forecast period.

On the other side, increasing morbidity due to sleep disorder has increased the healthcare cost, and related side effects of the drugs, and increasing patent expiries that are used in treating sleep disorders which would impede the market growth during the forecast period.  The treatment for include medication, better sleeping habits, and devices. Medicines such as, Hetlioz (tasimelteon) by Vanda Pharmaceuticals, Intermezzo (zolpidem tartrate sublingual tablet) by Transcept Pharmaceuticals, and Silenor (doxepin) by Somaxon Pharma are some of the FDA approved drugs that are observed to be beneficial during the treatment of sleep disorders.


The industry is segmented on the basis of disorder type, device, treatment, and geography. Based on disorder type, the market is bifurcated into sleep apnea, sleep breathing disorders, insomnia, hypersomnia, circadian rhythm disorders, parasomnia, and sleep movement disorders. on the basis of devices, the market is segmented into sleep apnea devices, sleep laboratories, and mattresses & pillows. By Treatment, the market is further bifurcated as psychiatric treatment, behavioral treatment, cognitive behavioral therapy, and medication therapy.



The market for sleep disorder in North America generated the highest revenue in 2017, and is expected to be the leading region globally during the forecast period. High number of patient population suffering the sleeping disorders is the primary factor accountable for the highest market growth. According to the US Department of Health and Human Services reports, approximately 20% Americans are suffering from sleep disorder. Thus, increasing demand for early treatments along with increasing patient pool, and growing patient awareness for proper diagnosis methods are factors boosting the growth in North America.

Asia Pacific is estimated to be the fastest growing region in terms of revenue. Growing awareness about sleep disorders and developing healthcare infrastructure are some of the factors that are projected to generate lucrative opportunities for the market in APAC.

The major key players operating in the Sleep Disorder industry include GlaxoSmithKline plc, Becton Dickson and Company, Cardinal Health, Natus Medical Incorporated Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., and Teva Pharmaceutical Industries Ltd. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.


Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,

Gold Nanoparticles Market Application, Revenue Status, Leading Player, Demand, Growth, Future Opportunity & 2026 Forecast

The global gold nanoparticles market is anticipated to reach USD 1.52 billion by 2026 and is anticipated to grow at a CAGR of 10.2 % from 2018 to 2026. Gold nanoparticles market is anticipated to witness significant growth over the forecast period. Growing demand for nano technological medical products, inherent advantages of gold nanoparticles, as well as growing application portfolio in medical field are expected to boost market growth. The global growth in the electronics industry are also expected to contribute to the overall market growth.

Inefficient tumor therapy, less developed drug targeting methods, drug resistant tumors, are a major cause for rising number of deaths due to cancer ailments. Gold nanoparticle enables efficient drug delivery, enhanced bio-imaging as well as aid in the selectivity of a wide range of drugs. The growing number of cancer ailments combined with the effect of gold nanoparticles is expected to benefit the market demand.


Gold nanoparticles exhibit several advantages over their other conventional counterparts. Such advantages include high surface area, unique physical, chemical as well as optical properties, high surface area, biocompatibility, as well as conjugation with other molecules enable their widespread applicability. Such trends are expected to propel market growth.

Gold nanoparticles are used as conductors in electronic applications such as electronic chips to conductors. The optimization and miniaturization are the major factors driving the electronics industry. Gold nanoparticles aid in these efforts of the electronics industry. The growth of the electronics industry in regions such as Asia Pacific are expected to aid the global market demand growth. 

The food & beverage industry utilize the colorimetric sensors manufactured by utilizing these metal nanoparticles. These sensors aid to qualify whether the food is fit for consumption or not. Rising awareness regarding the quality of food, concerns over food quality scams, and prevalent rules and regulations have forced food manufactures to manufacture high quality food. Such trends are expected to drive the gold nanoparticles market demand.


Toxicity of gold nanoparticles is expected to restrain market growth. Prescribed regulations aimed at containing this toxicity have to be abided by manufacturers. Industry participants have developed novel manufacturing methods which eliminate the usage of such toxic substances in their manufacturing processes.

Gold nanoparticles are used in memory devices. These products are also used to manufacture insulators which display excellent stability and also contribute to the prevention of charge accumulation. Due to their excellent catalytic as well as conductive properties, electronics industry is widely utilizing this material.

Research and Development activities are influencing the market growth. Researchers have developed products which can attract and destroy the viruses in the body. These products mimic the human body cells. These products can also be used to cure antimicrobial diseases. Different materials have also been developed to be used to treat ageing skin diseases. The growing medical industry is benefitting the market demand.

The prevalent medical industry in North America, as well as strong presence of industry participants is contributing to the regional demand. Strong demand from countries such as China, India and Japan is propelling the Asia Pacific market growth. Companies are focusing on developing regions to gain market share.


About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,

Animal Feed Enzymes Market Analysis, Region, Demands And Forecasts Report 2020-2026

The global animal feed enzymes market size is expected to reach USD 1.88 billion by 2026 and is estimated to grow at a CAGR of 7.3 % from 2018 to 2026. The market is anticipated to grow significantly over the forecast period owing to factors such as rising cost of feedstock, increasing meat consumption and rising pressure to increase the overall animal yield. The market is also anticipated to grow due to the rising awareness regarding the benefits of animal feed enzymes particularly in emerging regions such as Asia Pacific.

These additives result in the maintenance of proper overall health of animals. They result in the improvement of digestion of essential nutrients such as proteins as well as increase in the availability of amino acids. They also offset the negative effects of undigested nutrients in the gut health. Such trends are benefitting the overall market growth.


There has been a rapid growth in the overall world population thus putting strain on the available food resources. This has put pressure on the animal husbandry participants to maximize output while reducing the usage of resources. Enzymes aid in these efforts as they help in proper absorption as well as digestion of nutrients.

Companies are concentrating on the developing regions such as Asia Pacific to gain maximum share in the animal feed enzymes market. BASF and Biomin announced the launching of a new phytase product for the Vietnamese feed industry. Some of the major market players for Animal Feed Enzymes include Chr. Hansen Inc, BASF Corporation, Bio Vet JSC, DuPont, Enmex SA De CV, Adisseo France, Alltech, Novozymes, AB Enzymes GmbH, Advanced Enzymes Technologies Limited, and Lesaffre Group.

Grains which are normally utilized in the production of animal feed such as barley, corn and wheat have hard coating which does not completely break even during the milling process. The coating is indigestible. However, these additives result in the degradation of these cover molecules thus aiding the overall digestive process of animals as well as the proper maintenance of gut health.


Meat is considered as an essential part of the diet as it incorporates many valuable nutrients that are highly beneficial for health. Meat and meat products contain protein, micronutrients, and minerals that are beneficial for growth and development. Moreover, meat processing offers improved food safety, reduced price, and extended shelf life. Rising demand of meat across the globe is expected to favorably benefit the market growth.

Asia Pacific is the most lucrative regional market, where the latest demand has been supported by rising demand of the developing countries, primarily of Southeast Asian region and Indian Subcontinent. China, Japan, Western Europe, and the United States are some of the countries contributing significantly for the industry growth.

Growing population coupled with rising incomes has increased the demand for meat. However, at the same time, it has left limited space for livestock expansion. There should be an optimal usage of existing food resources. Usage of animal feed enzymes results in a rise in immunity of the livestock thus reducing the death caused due to the various diseases.


About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,

Mesenchymal Stem Cells Market Trends, Global Demand, Industry Growth,In-Depth Analysis And Opportunities Till 2026

The global mesenchymal stem cells market size to reach USD 2,518.5 Million by 2026, growing at a CAGR of 7.0% during forecast period, according to a new research report published by Polaris Market Research. The report provides an extensive analysis of present market dynamics and predicted future trends. The market was valued at USD 1,335.1 million in 2017. In 2017, the drug discovery application dominated the market, in terms of revenue. North America region is observed to be the leading contributor in the global market revenue in 2017.

are adult stem cells, which are traditionally found in the bone marrow. However, they can also be parted from other available tissues including peripheral blood, cord blood, fallopian tube. These stem cells mainly function for the replacement of damaged cell and tissues. The potential of these cell is to heal the damaged tissue with no pain to the individual. Scientists are majorly focusing on developing new and innovative treatment options for the various chronic diseases like cancer. Additionally, the local governments have also taken various steps for promoting the use of these stem cells.


The significant aspects that are increasing the development in market for mesenchymal stem cells consist of enhancing need for these stem cells as an efficient therapy option for knee replacement. Raising senior populace throughout the world, as well as increasing frequency of numerous persistent conditions consisting of cancer cells, autoimmune illness, bone and cartilage diseases are elements anticipated to enhance the market development throughout the forecast period.  The mesenchymal stem cells market is obtaining favorable assistance by the reliable federal government policies, as well as funding for R&D activities which is anticipated to influence the market growth over coming years. According to the reports released by world health organization (WHO), by 2050 individuals aged over 60 will certainly make up greater than 20% of the globe’s population. Of that 20%, a traditional quote of 15% is estimated to have symptomatic OA, as well as one-third of these individuals are expected to be influenced by extreme specials needs. Taking into consideration all these aspects, the market for mesenchymal stem cells will certainly witness a substantial development in the future.


Polaris Market Research has segmented the global mesenchymal stem cells market on the basis of source type, application and region:

Mesenchymal Stem Cells Market, 

By Source (Bone Marrow, Umbilical Cord Blood, Peripheral Blood, Lung Tissue, Synovial Tissues, Amniotic Fluids, Adipose Tissues); 

By Application (Injuries, Drug Discovery, Cardiovascular Infraction, Others)

Increasing demand for better healthcare facilities, rising geriatric population across the globe, and continuous research and development activities in this area by the key players is expected to have a positive impact on the growth of Mesenchymal Stem Cells market. North America generated the highest revenue in 2017, and is expected to be the leading region globally during the forecast period.  The Asia Pacific market is also expected to witness significant market growth in coming years. Developing healthcare infrastructure among countries such as China, India in this region is observed to be the major factor promoting the growth of this market during the forecast period. 

The major key players operating in the industry are Cell Applications, Inc., Cyagen Biosciences Inc. Axol Bioscience Ltd., Cytori Therapeutics Inc., Stem cell technologies Inc., Celprogen, Inc.  BrainStorm Cell Therapeutics, Stemedica Cell Technologies, Inc. These companies launch new products and undertake strategic collaboration and partnerships with other companies in this market to expand presence and to meet the increasing needs and requirements of consumers.


About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , ,

Myasthenia Gravis Disease Market Developments Analysis Based On Technological Growth And Scope 2020 To 2026

The global Myasthenia Gravis Disease Market is anticipated to exceed USD 2,538.6 Million by 2026 according to a new research published by Polaris Market Research. In 2017, the diagnosis segment dominated the global market, in terms of revenue. Myasthenia gravis disease is characterized by rapid fatigue and weakness of any muscles under person’s voluntary control. Though myasthenia gravis can affect people of any age, it’s more common in women younger than 40 and in men older than 60. In General, myasthenia gravis disease is caused by a breakdown in the normal communication between muscles and nerves. There is no accurate cure for MG disease, however, appropriate and early treatment can help to control symptoms, such as double vision, difficulties with speech, chewing, swallowing and breathing, weakness of arm or leg muscles, and drooping of eyelids.

The global Myasthenia Gravis Disease market is majorly driven by the need to prevent declining quality of life owing to myasthenia gravis disease. Moreover, growing R&D initiatives for novel therapies are another factor boosting the market growth. In addition, key players are also involved in innovative research to launch the affordable therapeutics for such disease. However, the unfamiliarity with early symptoms as well as signs and high cost associated with the treatment are factors hampering the market growth.


The global Myasthenia Gravis Disease Market is segmented on the basis of diagnosis, treatment, end-user, and region. On the basis of diagnosis, the market is categorized into Imaging, Blood Tests, Electrodiagnostic, and Edrophonium Test. The imaging segment is further bifurcated into X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and others. On the basis of treatment, the market is segmented into Medication, Surgery, and HSCT. The end-user is further segmented in to Hospitals, Clinics, and Academic Research Institutes.

Geographically, North America accounted for the largest share in the global Myasthenia Gravis Disease Market in 2017. The major factors accounted for the high market growth includes high occurrence of disease such in North America.


Moreover, Asia Pacific is estimated to generate the lucrative market growth during the forecast period. Growing initiatives by government and private organizations for generating novel control treatment are factors estimated to propel the myasthenia gravis disease market growth in Asia Pacific. In addition, increasing awareness about neuromuscular disorders and vast improvement are boosting the market growth in APAC.

The leading companies profiled in the Myasthenia Gravis Disease Market report include Alexion Pharmaceutical Inc., Avadel Pharmaceuticals plc, CSL Behring, Grifols S.A., Baxter International Inc., Shire plc, Novartis AG, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, and Valeant Pharmaceuticals International Inc. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.


About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,

Monday, 11 May 2020

Immuno Oncology Market Application, Revenue Status, Leading Player, Demand, Growth, Future Opportunity & 2025 Forecast

The global immuno-oncology market size is expected to reach USD 38.89 billion by 2025 according to a new study by Polaris Market Research this report gives a detailed insight into current market dynamics and provides analysis on future market growth.

Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer. This therapy uses constituents made by the body or in a research laboratory to improve or reestablish the immune system function.

Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells. Currently, world is at the forefront of this science with several compounds in development that are being investigated for use in a variety of cancers, as well as an approved immuno-oncology medicine that continues to be studied for new uses. The more precise targeting of patients for selected therapies is another important area of focus in oncology. Clinical biomarkers and pharmacogenomic studies are increasingly used to identify groups and sub-groups of patients most likely to benefit from an investigational agent in order to maximize its potential benefits.



The global immuno-oncology market is driven by the factors such as rising occurrence of different forms of cancer, technological advancements in the field of immune oncology for cancer treatment, and rising awareness concerning the benefits of ablation procedures over conventional treatment procedures. Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally. Additionally, the developments in oncology treatments, leading to the increased development of pioneering products are also advancing towards significant growth of the global Immune Oncology market.
  
The increasing trend was also seen in the research in the novel agents and increase in the number of clinical trials in combinations as well as monotherapy. The most notable new agents in Immuno-Oncology are IDO’s, LAG-3, TIGIT, TIM-3, VISTA, KIR, NKG2A, B7-H3/H4. The Report has also emphasized on the Oncolytic viruses, Neo-Antigen therapies, TCR Therapies and CAR-T therapies.

To customize the study according to your specific requirements please click At : https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market/request-for-customization

On the basis of treatment type, the global immuno-oncology market is segmented into Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines. Checkpoint inhibitors were the largest treatment process segment in 2019 that accounted for 55.2% of the overall revenue. On the basis of novel targets, the global market is segmented into IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i. VEGFi was the largest novel target segment that was used for immuno-oncology treatment processes in 2019 with a total market share of 11.2%. on the basis of cancer type, the global immuno-oncology Market is segmented into Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Head, face & Neck Cancer, Bladder Cancer, Classical Hodgkin’s Lymphoma, Merkel Cell, and carcinoma. Revenue share of immuno-oncology treatment for classical hodgkin’s lymphoma was the largest in 2019 i.e. 15.31% among the listed tumor types in the report.

On the basis of geography, North America was the largest regional market in 2019. High levels of spending on cancer treatments, also U.S. being one of the major country y with a huge population of cancer affected people on a global scale, the country being the host to the development of this technology, higher frequency of innovations of immuno oncology treatments or processes in the region specially in the U.S. etc., all of these factors have driven significant investment and alongside the demand for IO in the region. These factors have driven the North American market since the inception of this technology and over the forecast period it is expected to increase further.

Some of the key players operating in global immuno-oncology market are Bristol Myers Squibb, Merck, AstraZeneca, Roche Holding AG, Pfizer Inc., and Incyte Corporation among others.

To gain more insights into the market with detailed table of content and figures, click here: https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market/toc

Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
on No comments:

Narcolepsy Therapeutics Market Size, Growth Analysis, Opportunities, Business Outlook And Forecast To 2026

The Global Narcolepsy Therapeutics Market is anticipated to reach over USD 3263.65 Million by 2025 according to a new research published by Polaris Market Research.

Narcolepsy is a therapeutic disorder which is categorized by prodigious daytime sleepiness as well as sudden attacks of sleep. In some cases, this chronic sleep disease can lead to an abrupt loss of muscle tone (cataplexy), leading to loss and weakness of muscle control. Some of the most common indications of narcolepsy are daytime sleepiness, hallucinations, fragmented sleep & insomnia, and sleep paralysis.

Growing incidence of narcolepsy and increasing overweight populace are the major factors estimated to drive the global narcolepsy therapeutics market growth. For instance, according to the Sleep Science journal 2017 report, it was estimated that around 1 in every 2,000 people across the globe are suffering from narcolepsy disorder. Moreover, according to the Australian Institute of Health and Welfare, around 63% of the Australian individuals who are aged over 18 years were estimated to be obese or overweight. Additionally, growing research and development activities and growing demands for effective treatment of the disease are another factors expected to boost the market growth. However, low per capita healthcare spending and lack of awareness majorly in middle income and lower-income economies is estimated to hinder the global narcolepsy therapeutics market during the forecast period.


Some major key players in global Narcolepsy Therapeutics Market include Addrenex Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Cephalon, Inc., Evotec AG, Graymark Healthcare, Inc., Hypnion, Inc., Jazz Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. among others.

The global Narcolepsy Therapeutics Market is segmented on the basis of product, type, and geography. On the basis of product, the global Narcolepsy Therapeutics Market is segmented into Sodium Oxybate, Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, and Tricyclic Antidepressants. In 2017, Sodium oxybate was estimated to domkiat5e the market segment. The dominance is due to the presence of favorable reimbursement guidelines, the high cost of this drug, and the increasing awareness levels relating to diagnosis & associated treatments of the disease. On the basis of type, the global Narcolepsy Therapeutics Market is segmented into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy. In 2017, the Narcolepsy with cataplexy segment was estimated to dominate the market growth. The dominance is attributed to the growing incidence of cataplexy as a major indication in patients.

To customize the study according to your specific requirements please click At : https://www.polarismarketresearch.com/industry-analysis/global-narcolepsy-therapeutics-market/request-for-customization

On the basis of region, the global Narcolepsy Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe was estimated to dominate the global Narcolepsy Therapeutics Market. The dominance is majorly attributed to the well-established healthcare organizations, rising R&D initiatives for the expansion of novel drugs, and high incidence of people suffering from such disorder. However, Asia Pacific is expected to dominate the global Narcolepsy Therapeutics Market during the forecast. Rising disposable income, increasing investments in biotechnology and pharmaceutical sectors, economic development, supportive government initiatives, and rising awareness among people regarding the appropriate therapies are the factors expected to significantly boost the Narcolepsy Therapeutics Market in the Asia Pacific.

To gain more insights into the market with detailed table of content and figures, click here: https://www.polarismarketresearch.com/industry-analysis/global-narcolepsy-therapeutics-market/toc

Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
on No comments:
Labels: , , ,

Fire Safety Equipment Market Size, Growth Analysis, Opportunities, Business Outlook And Forecast To 2026

The global fire safety equipment market size is projected to reach USD 114.1 billion by 2026 growing at a CAGR of 9.1% from 2019 to 2026, according to a new research report published by Polaris Market Research. The report “Fire Safety Equipment Market Share, Size, Trends, Industry Analysis Report By Product Type (Fire Detection, Fire Suppression, Fire Analysis, Fire Response, Others); By Technology (Active Fire Safety, Passive Fire Safety); By End-User (Commercial, Residential, Industrial, Others) By Region, Segments & Forecast, 2019 – 2026” provides a wide-ranging assessment of the market with insights on the current and future market trends.

Increase in casualties of life and property due to fire related incidents has led to importance of fire safety systems in multiple industries. Strict government enforcements and regulations related to workplace safety, and rise of automation due to smart homes/building projects are factors further contributing to the growth in adoption of fire safety equipment. Also, safety concerns have compelled strict adherence to building safety codes. Moreover, ever increasing demand from industries including oil and gas, mining has further enhanced the market growth. Emergence of new technologies such as scada solutions and wireless sensor networks provide significant growth opportunities in this market. However, high initial investments required for installation of fire safety equipment might limit the market growth in some cases.


The oil and gas, and mining sector involves high risk and is exposed to fire accidents due to presence of highly inflammable and combustible material including oil, gasoline, etc. To tackle and avoid such accidents, proper fire detection and prevention equipment are mandatorily required. Vendors are increasingly investing in developing new fire suppression systems to protect critical environment and investments across the sites. It is observed that risk management strategies are increasingly becoming an integral part across in oil and gas facilities; as a part of these strategies high quality fire safety installations are gaining traction in the market. 
  
During 2018, North America region account for the highest share amongst all regions in the fire safety equipment market. This growth in this region attributed to introduction of stringent government regulations related to workplace safety and adoption of fire protection technology. Also, growing demand from manufacturing and mining industries has contributed to the rise in adoption of fire protection systems across North America. While, the increasing adherence to building safety codes along with the rise in automated systems in buildings further supports the market growth. Asia Pacific regional market is expected to grow at the highest CAGR during the forecast period majorly due to high growth in industrial and manufacturing sectors. Moreover, continual growth in demand from healthcare, mining, and commercial sectors provides further opportunities for market growth in this region.


Some of the key players profiled in the fire safety equipment market report include Honeywell, Hochiki Corporation, Minimax Viking, Gentex Corporation, United Technologies Corporation, Siemens Building Technologies, Johnson Controls, Halma, Securiton AG, Tyco International.

  
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
on No comments:
Labels: , ,

Picture Archiving and Communication Systems Market Regional Analysis Focus On Business Economy With Innovative Growth Forecast 2020 To 2026

The global Picture Archiving and Communication Systems (PACS) Market is anticipated to exceed USD 3 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the cloud-based segment dominated the global market, in terms of revenue. North America is expected to be the leading contributor to the global market in 2017.

Picture archiving and communications systems (PACS) is a term used for clinical or medical imaging technologies that allow exchange and storage of images across multiple sources. Such system provides cost-effective and manageable access to stored images via several source modalities such as PET (positron emission tomography), X-ray plain film, ultrasound, CT (computed tomography), nuclear medicine, and MRI (magnetic resonance imaging).

The leading companies profiled in the Picture Archiving and Communication Systems (PACS) Market report include FUJIFILM Medical Systems, Carestream Health, Agfa-Gevaert Group, INFINITT Healthcare Co. Ltd., Merge Healthcare Solutions Inc., Mckesson Corp., GE Healthcare, Koninklijke Philips N.V., Sectra AB and Siemens Healthineers. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/picture-archiving-and-communication-systems-pacs-market/request-for-sample

The PACS market includes several opportunities that continue to develop with the advancement of healthcare practices. Thus, the development of scalable and interoperable PACS is a significant opportunity for the PACS market. Increasing demand for the digital medical records with patient images, and impart this information to health exchange platforms, is expected to mark the significant market growth of PACS market during the forecast period the forecast period. The cloud-based system is a relatively new concept, and is estimated to grow continuously at a constant during the forecast period. However, the global Picture Archiving and Communication Systems (PACS) Market also face several challenges relating to effective yet secure integration and transmission of medical images and patient data between radiologists and other medical specialists.

Geographically, the existence of several PACS manufacturing corporations in North America is anticipated to play a vital role for cloud-based PACS segment in the North American PACS market. Moreover, Cloud-based PACS segment is estimated to witness healthy growth in European and Asia Pacific Market due to the increased usage of cloud-based PACS majorly in diagnostic centers and large hospitals in these regions.
  

Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , ,

Digital Transaction Management Market Latest Comprehensive Research Report, Swot Analysis And Covid-19 Impact Analysis

The global Digital Transaction Management (DTM) Market is projected to reach USD 10,528.2 million by 2026, according to a new research published by Polaris Market Research. Digital transaction management is method of transforming traditional document-based processes to digital/electronic platform. In 2017 the electronic signatures solution segment dominated this market and in terms of regions North America is observed to be the leading contributor in the global market.

This market is majorly strengthened by increasing importance and focus on cloud services and IT security. There is a strong preference in the banking and financial services industry for adoption of digital transaction management solutions due to changing customer requirement. Thus, steady flow in volume of transactions done via digital platforms such as e-wallets, internet banking, etc. presents transaction service providers with a genuine growth opportunity in the digital transaction management market. Furthermore, extensive adoption and acceptance of various electronic devices along with the convenience of usage and transacting through these devices is pushing enterprises in various industries towards digitally transforming their operations in line with the dynamic consumer requirements and preferences. All these factors are eventually expected to have a positive impact on the progress of digital transaction management market across the world.


The market segments for digital transaction management are based on solutions, industry vertical, end user, and region. The digital transaction management solutions segment includes market for electronic signatures, document digitization, workflow automation, and security & compliance sub segments. Electronic signatures segment is expected to dominate this market in terms of digital transaction management solutions. End user segmentation in the digital transaction management market report covers SMBs and large enterprises. Major industry verticals in this market include BFSI, construction & real estate, education, government, healthcare, and IT & Telecom.

North America is observed to be the leading region in this market during 2017, and is expected to lead the global digital transaction management market throughout forecast period. Presence of established players and cloud infrastructure in this region, and growing trend of investments in cloud-based services drive the market growth in the region. Also, the growing demand from banking sector due to its strong preference for digital platforms, and further technological advancements support market growth in this region.


Some of the leading companies operating in the Digital Transaction Management (DTM) market include DocuSign Inc., Fluix, Kofax Inc., Captricity, Box, Namirial Spa, ZorroSign Inc., Insight Enterprises Inc., AssureSign LLC, ThinkSmart LLC, eOriginal, Inc., Euronovate S.A., DocuFirst, OneSpan, HelloSign, Accusoft Corporation, Connective. These companies offer innovative solutions to meet the increasing needs and requirements of consumers from multiple industry verticals


Contact us-
Polaris Market Research
Phone: 1-646-568-9980
on No comments:
Labels: , ,
Subscribe to: Comments (Atom)